Patient-First (Pts)
A constant reminder that the ultimate goal is improving the patient experience.
Patient-first innovation for precision targeting
pts66 explores the path to targeted therapeutic delivery.
The journey toward precision treatment is complex, but the ambition is clear: create a future in which targeted therapeutic delivery becomes a reliable reality for patients.
Vision
To achieve a future where targeted therapeutic delivery is a reality for patients, overcoming historical roadblocks through collaborative innovation and a patient-first approach.
Mission
To identify and resolve the fundamental challenges of targeted therapeutic delivery by coordinating a diverse ecosystem of stakeholders and building the right culture to drive this ambitious technological journey forward.
Origin & Purpose
Why pts66 was founded
Overcoming the systemic roadblocks between academic research and clinical practice to ensure targeted therapies reach patients.
Initiated Summer 2026
Future Non-Profit / Foundation
From Fragmented Funding to Sustained Clinical Translation
The pts66 initiative was initiated in the summer of 2026 by Christophe Chautems. Looking ahead, it is foreseen that the initiative could evolve toward an independent association, a foundation, or a non-profit organization to steward this mission long-term for public and patient benefit.
The decision to launch pts66 was driven by a glaring reality: while significant funding flows into targeted therapeutic delivery, it often lacks the critical mass and continuity required to produce a definitive clinical breakthrough and transform routine medical practice.
The 3–5 Year Grant Cycle Trap
Too many projects run on short 3- to 5-year grants and must pause until the next funding round arrives. When restarted, projects often begin again with new PhD students without proper knowledge transfer, causing valuable momentum and institutional memory to be lost.
Competition Over Collaboration
Research groups are too often competing against each other for grants, journal publications, and visibility rather than collaborating. This rivalry fragments talent and slows down collective progress on shared technical hurdles.
The Multidisciplinary Imperative
Targeted delivery demands tight synergy between magnetic navigation, robotics, chemistry, regulatory science, and clinicians. Without strong, persistent multidisciplinary collaboration, targeted therapeutic delivery will never reach the patients.
What pts66 means
The name pts66 is a synthesis of our human values and our technical ambition.
The 66
A nod to the spirit of the 1960s—an era of bold, moonshot engineering—and the inspiration of Fantastic Voyage, where the dream of navigating the human body first captured the public imagination. It also symbolizes the "road"—the deliberate, necessary journey of bringing treatments from the lab to the patient.
Precision Targeting System (PTS)
The technical foundation for delivering more precise, patient-centered therapies.
Individual patient focus
Every person's journey and needs are unique, and the work honors that individual path.